The Ultimate Cd20 Monoclonal Antibody (qch6a7), Brilliant Ultra Violet™ 661 Highly Recommended [ocCQKHAf]

CD20 Monoclonal Antibody (QCH6A7)

The CD20 Monoclonal Antibody (QCH6A7) is a cutting-edge reagent designed for researchers and clinicians in the field of immunology and oncology. This antibody specifically targets mouse CD20, a crucial B cell-specific marker expressed on various stages of B cell development. The QCH6A7 antibody offers exceptional staining intensity in flow cytometric assays, making it a powerful tool for investigating B cell populations and their roles in disease processes. Its unique ability to bind to CD20 without shedding or internalization upon antibody binding sets it apart from other B cell antigens, making it ideal for depleting B cells and exploring the immune system's response in various conditions.

Product Features and Specifications

The QCH6A7 antibody boasts several key features that enhance its performance and versatility. It is conjugated with Brilliant Ultra Violet™ 661 (BUV661), a tandem dye that emits at 660 nm, ideal for use with cytometers equipped with an ultraviolet (355 nm) laser. This dye is highly sensitive to photo-induced oxidation, so it is essential to protect the vial and stained samples from light. The antibody has been rigorously tested and is suitable for flow cytometric analysis of mouse splenocytes and bone marrow cells. With a recommended concentration of less than or equal to 1.0 µg per test, the QCH6A7 antibody offers flexibility in experimental design. It is also compatible with Super Bright Complete Staining Buffer or Brilliant Stain Buffer™ to minimize non-specific polymer interactions, ensuring accurate and reproducible results.

Applications and Benefits

The QCH6A7 antibody is a valuable resource for researchers studying B cell lymphomas and various autoimmune diseases such as rheumatoid arthritis and type I diabetes. Its ability to effectively deplete B cells and its role as an immunotherapeutic target make it a powerful tool for both diagnostic and therapeutic applications. The following are some of the benefits of using the QCH6A7 antibody:

Improved Staining Intensity: Significantly enhanced staining intensity compared to other clones, enabling better detection of CD20+ cells.

Wide Range of Applications: Suitable for flow cytometric analysis of mouse splenocytes and bone marrow cells, providing valuable insights into B cell biology.

Enhanced Research Outcomes: Facilitates the study of B cell-mediated diseases and the development of novel immunotherapies.